Are drug-eluting stents using biodegradable technology safer than durable coatings?

 

With an unrestricted educational grant from BIOSENSORS INTERNATIONAL

 

Chairperson: A. Colombo Co-chairperson: E. Grube

 

Objectives:

 

_ To understand differences between biodegradable

 

and permanent polymers in drug-eluting stents

 

_ To understand how clinical studies, methodology

 

and design impact the assessment of stent efficacy

 

and safety

 

_ Introduction and objectives - A. Colombo

 

_ Are there differences in healing between

 

biodegradable and durable polymers? - R. Virmani

 

_ Optical coherence technology results from

 

biodegradable versus durable polymers

 

_ How to design clinical trials to evaluate long-term

 

safety of DES - L. Mauri

 

_Biodegradable polylactide / Biolimus A9 technology:

 

what have we learned from 6000 patients? - S. Windecker

When safety meets efficacy - Nobori drug-eluting stent

With an unrestricted educational grant from

 

TERUMO EUROPE

 

Chairperson: B. Chevalier Co-chairperson: P. Urban

 

Objectives:

 

_ To evaluate the impact of drug-eluting stents on

 

endothelial function

 

_ To explore potential value of abluminal application

 

of biodegradable polymer in drug-eluting stents

 

_ Introduction and objectives - B. Chevalier

 

_ Endothelium after stenting: quantity versus quality

 

R. Virmani

 

_ Assessment of endothelial function with first

 

generation DES - S. Windecker

 

_ Nobori endothelial function study - M. Ostojic

 

_ Discussion: endothelial function in the era of DES

 

_ Nobori 1 results update - S. Silber

 

_ Nobori long-term results and future clinical

 

programme - G.B. Danzi

 

_ Discussion: critical appraisal of Nobori results

 

Wah!!!!!!!!!!!!!!!!!Huat Liao Lah!!!!!!!!!!!!!!BUY more now dun miss it!!!!!!!!!!!

CHEER!!!!!!!!!!!!!!!!!!!!!!!!!!!FIRST!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!